So let me get this straight...their assuming 28,800 - 47000 sales annually at 15k a pop, possibly 2 treatments per patient, high margins, manufacturer as good as in place? And this is just for pancreatic cancer. On first glance it seemed like I may have missed the boat, but on second thought, time to load up the super ac I think :)
I wonder when the market will wake up? Reminds me of another stock I have held - LNC. Totally different sector I know, but remember buying in at 18c and holding for a while thinking "when will the market take notice?" Ended up selling for a loss at 16c, only to watch it go to 70c then $1.40 then $5 plus. We live and learn.
I think I'll stick around to see where this goes.
OSL Price at posting:
12.5¢ Sentiment: Buy Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)